Revolution Medicines, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Revolution Medicines, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Revolution Medicines, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 167M shares, a 52.7% increase year-over-year.
  • Revolution Medicines, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 113M shares, a 40.3% increase from 2022.
  • Revolution Medicines, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 80.6M shares, a 10.7% increase from 2021.
  • Revolution Medicines, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 72.8M shares, a 32.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 167M +57.6M +52.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 165M +58.3M +54.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 165M +69.9M +73.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 113M +32.5M +40.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 109M +24.5M +29% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 107M +32.6M +43.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 94.8M +20.7M +27.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 80.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 84.7M +11.2M +15.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 74.3M +881K +1.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 74.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q3 2021 73.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 73.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.